Cullinan Oncology Inc Stock
Cullinan Oncology Inc Stock price
Key metrics
| Market capitalization | $508.12m |
| Enterprise Value | $204.29m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 0.92 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-208.93m |
| Free Cash Flow (TTM) Free Cash Flow | $-150.21m |
| Cash position | $303.83m |
Is Cullinan Oncology Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.
Cullinan Oncology Inc Stock Analysis
Analyst Opinions
11 Analysts have issued a Cullinan Oncology Inc forecast:
Analyst Opinions
11 Analysts have issued a Cullinan Oncology Inc forecast:
Financial data from Cullinan Oncology Inc
| Mar '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -209 -209 |
22%
22%
|
EBIT (Operating Income) EBIT | -209 -209 |
22%
22%
|
| Net Profit | -179 -179 |
35%
35%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Cullinan Oncology Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cullinan Oncology Inc Stock News
Company Profile
Cullinan Oncology, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.
| Head office | United States |
| CEO | Nadim Ahmed |
| Employees | 85 |
| Founded | 2016 |
| Website | cullinantherapeutics.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
